Click below to register.


San Antonio Marriott Rivercenter

101 Bowie Street
San Antonio, Texas

Room: Salon ABF

Registration and Breakfast 5:15 AM – 5:45 AM
Interactive CME Activity 5:45 AM – 7:15 AM

This educational activity is supported by an educational grant from GlaxoSmithKline.

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.

Chronic obstructive pulmonary disease (COPD) is a complex, heterogeneous disease. Management of patients with COPD has been complicated by newly approved guidelines that incorporate novel escalation strategies with dual bronchodilation treatments. Fixed dose combination (FDC) dual bronchodilation, consisting of a long-acting ß agonist (LABA) combined with a long-acting muscarinic antagonist (LAMA), has emerged as an effective strategy for patients who require escalation beyond LABA or LAMA monotherapy. For patients who require escalation beyond LAMA/LABA or other dual therapies, the FDA recently approved the first, and currently only, fixed-dose, once-daily triple therapy (LAMA/LABA/inhaled corticosteroid [ICS]) inhaler. Despite updated recommendations, there is limited practical guidance for individualizing therapy or identifying patients who may benefit from treatment escalation (ie, escalating from mono- to dual bronchodilation therapy or adding an ICS/escalating to triple therapy). In addition, lack of knowledge of appropriate COPD inhaler use and self-management strategies persist among patients/caregivers, precluding optimal therapeutic benefit and clinical outcomes. This live, interactive activity will feature 3 international experts in COPD, who will review and discuss the clinical science behind dual bronchodilation therapy, advances in triple therapy, and the new COPD recommendations, as well as implementation of practical individualized treatment and inhaler strategies for patients with COPD.

This goal of this CME activity is for physicians, physician assistants, nurse practitioners, and nurses who manage patients with COPD in pulmonology settings to develop the knowledge base to incorporate dual and triple brochodilation management strategies into their practice, based on the guideline recommendations, and to improve individualized treatment plans for their COPD patients.

After completing this activity, the participant should be better able to:
  • EVALUATE scientific evidence supporting the use of dual bronchodilation and triple drug therapy to improve lung function, manage symptoms, and reduce exacerbations in COPD.
  • UTILIZE the most up-to-date COPD guidelines on treatment initiation and escalation strategies that include dual bronchodilation and ICS.
  • EMPLOY strategies that provide disease education and inhaler training to patients with COPD.
  • DEVELOP individualized COPD maintenance treatment strategies, considering patient-specific appropriate use of dual bronchodilation and ICS therapies.
Continuing Education Information

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ASiM CE LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Activity Registration and Breakfast

Activity Overview and Goals

Addressing Unmet Needs of COPD Patients: Understanding the Problem
James F. Donohue, MD

Dual Bronchodilation and Advances in Triple Therapy
Nicola Alexander Hanania, MD, MS, FCCP, FERS

Current COPD Recommendations and Implementation of Individualized Treatment and Inhaler Strategies for COPD
MeiLan K. Han, MD

Question and Answer Session
Faculty Panel

Conclusions and Postassessment

This schedule is subject to change.

James F. Donohue, MD (Chair)
Professor of Medicine and Former Chief
of the Division of Pulmonary and
Critical Care Medicine
University of North Carolina at Chapel
Hill School of Medicine
Chapel Hill, North Carolina

MeiLan K. Han, MD
Internal Medicine
Division of Pulmonary and Critical Care Medicine
Director, Michigan Airways Program
University of Michigan Health System
Ann Arbor, Michigan

Nicola Alexander Hanania, MD, MS, FCCP, FERS
Associate Professor
Section of Pulmonary and
Critical Care Medicine
Director, Airways Clinical Research Center
Baylor College of Medicine
Houston, Texas

This educational initiative is designed for physicians, physician assistants, nurse practitioners, and nurses engaged in the care of patients with COPD in pulmonology settings.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Americans with Disabilities Act (ADA)
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Adrienne Roser prior to the live event at 908-253-9001 ext. 23.

There is no fee for this educational activity.

Submit a case to review at meeting:

<img src="" alt="procced to pretest" border="0" />

MyCMESite is published by ASiM CE, LLC, d/b/a ASiM 166 W. Main Street, Somerville, NJ 08876. (908) 253-9001. Copyright ©2017 by ASiM CE, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of ASiM CE LLC. Contact Us